Risk factors for Hepatitis C virus infection among blood donors in Georgia

European Journal of Epidemiology

Volumn 19, Issue 6, 2004, Pages 547-553

  Zaller, Nickolas ^a   Nelson, Kenrad E ^a   Aladashvili, Malvina ^b   Badridze, Nino ^b   Del Rio, Carlos ^c   Tsertsvadze, Tengiz ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AIDS and Clinical Immunology Research Center   (Georgia)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood donors; Georgia; Hepatitis C; Injection drug use; Transfusion transmitted infections

Indexed keywords

NUCLEIC ACID; VIRUS ANTIBODY;

ADULT; ARTICLE; BEHAVIOR; BLOOD; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CITY; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXAMINATION; FEMALE; GEORGIA (REPUBLIC); HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INJECTION; MALE; POPULATION; QUESTIONNAIRE; RISK FACTOR; SCREENING; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; BLOOD DONORS; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; GEORGIA (REPUBLIC); HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 3442883317     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000032352.29173.78     Document Type: Article

References (30)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902): 359-362.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905.
3. Ebeling F. Epidemiology of the hepatitis C virus. Vox Sang 1998; 74(Suppl 2): 143-146.
4. Moradpour D, Cerny A, et al. Hepatitis C: An update. Swiss Med Weekly 2001; 131: 291-298.
5. Thomas DL, Astemborski J, et al. The natural history of Hepatitis C infection: Host, viral, and environmental factors. JAMA 2000; 284: 450-456.
6. Memon MI, Memon MA. Hepatitis C: An epidemiological review. J Viral Hepat 2002; 9: 84-100.
7. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
8. Balasekaran R, Bulterys M, Jamal MM, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999; 94: 1341-1346.
9. Chiaramonte M, Stroffolini T, Lorenzoni U, et al. Risk factors in community-acquired chronic hepatitis C virus infection: A case-control study in Italy. J Hepatol 1996; 24: 129-134.
10. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000; 31: 756-762.
11. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J Med Virol 1999; 59: 290-296.
12. Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991; 13: 830-833.
13. Bad A, Akhtar S, et al. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Tropical Med Int Health. 2001; 6: 732-738.
14. Ackerman Z, Ackerman E, Paltiel O. Intrafamilial transmission of hepatitis C virus: A systematic review. J Viral Hepat 2000; 7: 93-103.
15. Kao JH, Hwang YT, Chen PJ, et al. Transmission of hepatitis C virus between spouses: The important role of exposure duration. Am J Gastroenterol 1996; 91: 2087-2090.
16. Kim YS, Ahn YO, Kim DW. A case-control study on the risk factors of hepatitis C virus infection among Koreans. J Korean Med Sci 1996; 11: 38-43.
17. Neal KR, Jones DA, Killey D, James V. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect 1994; 112: 595-601.
18. Yee LJ, Weiss HL, et al. Risk factors for acquisition of hepatitis C virus infection: a case control series and potential implication for disease surveillance. BMC Infect Dis 2001; 1(8).
19. Ruzibakiev R, Kato H, et al. Risk factors and seroprevelance of hepatitis B virus, hepatitis C virus, and human immunideficiency virus infection in Uzbekistan. Intervirology 2001; 1(44): 327-332.
20. Ho MS, Hsu CP, et al. High Rate of Hepatitis C Virus Infection in an Isolated Community: Persistent Hyperendemicity or Period-Related Phenomena? J Med Virol 1997; 52: 370-376.
21. Butsashvili M, Tsertsvadze T, et al. Prevelance of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001; 17: 693-695.
22. Alavian SM, Gholami B, et al. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastroenterol Hepatol 2002; 17: 1092-1097.
23. Chang CJ, Lin CH, et al. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol 1999; 15: 597-601.
24. Thorpe L, Quelle LJ et al. Hepatitis C Virus Infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000; 182: 1588-1594.
25. Roy E, Haley N, et al. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001; 165: 557-560.
26. Garfein RS, Vlahov D et al. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-Lymphotropic viruses. Am J Public Health 1996; 86: 655-661.
27. Delage G, Infante-Rivard C, et al. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology 1999; 116: 893-899.
28. Murill CS, Weeks H et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92: 385-387.
29. Kessler A, del Rio C, et al. The emerging HIV/AIDS epidemic in the Republic of Georgia. Int J AIDS and STDS (in press).
30. Skarbinski J, Walker HK, et al. The burden of out-of-pocket payments for health care in Tbilisi, Republic of Georgia JAMA 2002; 287: 1043-1049.